Kara Scheer, MBA, University of Chicago Booth School of Business, has over ten years of healthcare experience. She started her career at Epic Software Systems in 2012, and in 2017, she founded Salus Consulting, where she provided strategy and tailored guidance to clients comprising some of the leading healthcare organizations in the US. She has advised digital health and biotech startups in technology development, business model strategy, process improvement, financial modeling, and strategic execution. She is passionate about bringing innovation to market, improving the world through technology, and helping mission-based organizations succeed.

She currently serves as Director of Strategy and Business Operations at Belay Diagnostics, an early-stage brain cancer diagnostics startup in Chicago formed in 2022 that closed its Series-A funding round in October 2023 and is launching its first product in early 2024.